• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 11, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Feature

Accessing donor eyes for eye research in Australia – Heather Machin

by Myles Hume
October 3, 2023
in Feature, Ophthalmic insights, Opinion, Research
Reading Time: 5 mins read
A A
Heather Machin is the CERA biobank Lead, senior project manager.

Heather Machin is the CERA biobank Lead, senior project manager.

Share on FacebookShare on Twitter

For many researchers in Australia who are investigating the eye, access to end-of-life (deceased) donor eyes is paramount. Despite this, researchers who seek deceased human eye donations for their projects may not be prepared for the barriers they may face.

In Australia, access to deceased eye donations for research is through an eye or tissue bank. 

There are five banks that manage this in Australia, located in Adelaide, Brisbane, Perth, Melbourne, and Sydney. 

They work with Donatelife and the Australian Commonwealth Government’s Organ and Tissue Authority to recover and allocate tissue for transplantation, training, and research.

While each bank operates slightly differently, they generally work with end-of-life donation agencies and hospital and mortuary staff to identify deceased donors, discuss donation with the donor’s family, and then consent and recover the donation. 

They then allocate the donation to research groups with ethics approval, and approval by their bank.

Some banks require researchers to reimburse them for all or part of the costs they incurred to recover and provide the tissue, while others provide as gratis.  

While this process seems straightforward, in Australia – as elsewhere in the world – access to deceased research donation is limited. 

This is because the donation system has been established to support transplantation, with research demand emerging as an area of secondary need. There are several key reasons for research donation access limitations:

1. The health system [Medicare/private health insurance] reimburses the banks only when the donation is transplanted. This means most banks, unless they are reimbursed, do not have the resources to recover additional quantities of donations for research unless the research team reimburses them.

2. The public donation awareness programs, the donation system and end-of-life conversation focuses predominantly on transplantation. Therefore, donors and families have not had the chance to receive information about becoming a research donor, and in turn have to make the decision at the point-of-donation. 

3. In Australia, researchers have historically received eye donations as gratis. They have not had to budget and therefore do not have the resources ready to reimburse the bank. 

4. Demand from Australian researchers has increased in the last five years, meaning the few donations that are available must now stretch across more research projects. 

5. As researchers now require access to ‘big data’, individual research projects are now seeking greater quantities of donations. These are often above the ability of the current system. 

Collectively, this means researchers, regardless of obtaining ethics and bank approval to receive tissue, do not receive access to enough donations in their expected time frame. 

This means some researchers may have to amend their research protocol timeline and/or design. 

While addressing system-wide issues will take some time, researchers who need access to deceased human eye donations can help improve their access to tissue long term by connecting with their nearest bank before submitting grants and ethics applications. 

This will allow the bank to provide practical guidance on how to access donations to prepare the research team for any challenges ahead. 

Lastly, everyone can help share forward the importance of becoming an end-of-life donor for transplantation, training and research, and register themselves on the Australian Donatelife Register at: www.donatelife.gov.a/register-donor-today. 

NOTE: Find a local eye bank: ebaanz.org/about-us/#Eye-Bank-Members

Further reading: Machin H, Brown K, Sutton G, Baird P. Ocular Tissue for Research in Australia: Strategies for Potential Research Utility of Surplus and Transplant-Ineligible Deceased Donations. Translational Vision Science and Technology.  April 2020, Vol.9, 4. doi: doi.org/10.1167/tvst.9.5.4 

About the author:

Name: Heather Machin
Qualifications: RN MBA PhD
Primary place of work: The Lions Eye Donation Service and Corneal Research Unit, Centre for Eye Research Australia
Position: CERA Biobank Lead, Senior Project Manager
Location: Melbourne
Years in profession: 21

More reading

Registries and real world findings – A/Prof Mitchell Lawlor

Finding suitable front-of-house staff for optometry practices – Ilsa Hampton

Ethical commercialisation of modern healthcare businesses – Prof Alexander Holden

Related Posts

Australia's commonweath, state and territory treasurers support widening the scope of practice for optometrists. Image: Jason Bennee/stock.adobe.com.

OA welcomes political support for scope of practice reforms

by Rob Mitchell
December 10, 2025

Optometry Australia (OA) says it welcomes the announcement that Australia’s state and federal treasurers have agreed to support reforms that...

Actress and entrepreneur Naomi Watts is promoting eye health as part of healthy ageing. Image: Denis Makarenko/shutterstock.com.

Aussie star Watts, J&J team up to promote eye health

by Staff Writer
December 9, 2025

Johnson & Johnson, a global leader in eye health, has partnered with Australian Academy Award–nominated actress, producer, and entrepreneur Ms...

Holly Cafe worked her way through nearly every role on the retail side during her journey to partnership. Image: Holly Cafe.

Owning the vision – pathways to partnership

by Rhiannon Bowman and Rob Mitchell
December 8, 2025

Three dispensing and retail directors tell Insight how they made their way to investing in an optometry practice – sometimes...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited